
CJC-1295 No DAC
10 mg
Modified GHRH (1–29) analog without albumin binding, used as a short-duration receptor reference.
Free U.S. shipping $175+

GHRP-6 is a synthetic hexapeptide and one of the earliest characterized growth hormone releasing peptides, acting at the growth hormone secretagogue receptor.
Its long presence in the literature makes it a standard comparator in laboratory research on secretagogue receptor pharmacology, particularly in studies distinguishing receptor-mediated responses from off-target activity.
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
Analytical values reflect per-lot documentation and appear once a batch is released.
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
GHRP-6 emerged from the same 1980s program that produced the broader GHRP family. It preceded the identification of the endogenous ghrelin ligand for GHSR-1a.
The compound is widely cited in the historical development of growth hormone secretagogue research.

10 mg
Modified GHRH (1–29) analog without albumin binding, used as a short-duration receptor reference.

5/5 mg
Combined GHRH analog and secretagogue receptor agonist preparation for dual-input pituitary research.

5 mg
GHRH analog with Drug Affinity Complex modification for extended-duration receptor research.

10 mg
Second-generation growth hormone releasing peptide studied as a ghrelin receptor agonist reference.